ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets

D Dreymueller, S Uhlig… - American Journal of …, 2015 - journals.physiology.org
Acute and chronic lung inflammation is driven and controlled by several endogenous
mediators that undergo proteolytic conversion from surface-expressed proteins to soluble …

ADAM-family metalloproteinases in lung inflammation–potential therapeutic targets

D Dreymueller, S Uhlig, A Ludwig - 2014 - journals.physiology.org
1 ADAM-family metalloproteinases in lung inflammation – potential therapeutic targets 1 2
Daniela Dreymueller, Stefan Uhlig an Page 1 1 ADAM-family metalloproteinases in lung …

[PDF][PDF] ADAM-family metalloproteinases in lung inflammation–potential therapeutic targets

D Dreymueller, S Uhlig, A Ludwig - 2014 - scholar.archive.org
1 ADAM-family metalloproteinases in lung inflammation – potential therapeutic targets 1 2
Daniela Dreymueller, Stefan Uhlig an Page 1 1 ADAM-family metalloproteinases in lung …

ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets

D Dreymueller, S Uhlig… - American journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Acute and chronic lung inflammation is driven and controlled by several endogenous
mediators that undergo proteolytic conversion from surface-expressed proteins to soluble …

ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets

D Dreymueller, S Uhlig, A Ludwig - American Journal of Physiology …, 2015 - cir.nii.ac.jp
抄録< jats: p> Acute and chronic lung inflammation is driven and controlled by several
endogenous mediators that undergo proteolytic conversion from surface-expressed proteins …

ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets.

D Dreymueller, S Uhlig, A Ludwig - American Journal of physiology …, 2014 - europepmc.org
Acute and chronic lung inflammation is driven and controlled by several endogenous
mediators that undergo proteolytic conversion from surface-expressed proteins to soluble …